GeoVax Labs, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
GeoVax Labs, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • GeoVax Labs, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $29.9M, a 30.7% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $29.9M +$7.03M +30.7% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $22.9M +$2.73M +13.5% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $20.2M +$4.21M +26.3% Dec 31, 2021 10-K 2023-03-23
Q4 2020 $16M -$2.81M -15% Dec 31, 2020 10-K 2022-03-09
Q4 2019 $18.8M -$1.09M -5.5% Dec 31, 2019 10-K 2021-03-23
Q4 2018 $19.9M +$756K +3.95% Dec 31, 2018 10-K 2020-03-24
Q4 2017 $19.1M -$9.21M -32.5% Dec 31, 2017 10-K 2019-03-26
Q4 2016 $28.3M +$1.2M +4.43% Dec 31, 2016 10-K 2018-03-23
Q4 2015 $27.1M +$1.11M +4.26% Dec 31, 2015 10-K 2017-03-24
Q4 2014 $26M +$1.02M +4.08% Dec 31, 2014 10-K 2016-03-16
Q4 2013 $25M -$2.29M -8.4% Dec 31, 2013 10-K 2015-03-20
Q4 2012 $27.3M -$295K -1.07% Dec 31, 2012 10-K 2014-03-14
Q4 2011 $27.6M Dec 31, 2011 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.